Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
The epidemic of diabetes in the United States and around the world has forced researchers to try to help those who suffer from the disease manage their lives better. In particular, Type I cannot be prevented nor cured, and patients must monitor their blood sugar and injecting insulin with some frequency. In response, researchers have created and the FDA recently approved an artificial pancreas. Attend this webinar and learn more about this new live saving treatment.
Goals and Outcomes
Goals and Learning Outcomes
The goal of this webinar is to discuss the artificial pancreas and how it affects people with Type 1 diabetes. Upon completion, participants will be able to do the following:
  • Explain the functions of the pancreas and how the artificial pancreas is being used to mimic pancreatic endocrine functions.
  • Discuss statistics, prevalence and pathophysiology of Type 1 diabetes.
  • Identify the benefits and limitations of the artificial pancreas.
Details
Course Details

Course Originally Released on : 7/27/2015

WEB292

Course Author

Tracey B. Long

PhD, MS, MSN, RN, APRN-BC, CDCES, CNE, CHUC, COI, CCRN

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.